Previous research has associated poor health outcomes and increased health care use with household food insecurity (HFI), which can be dependent on context and environmental stressors, such as ...
The FDA has granted Breakthrough Therapy Designation for oral infigratinib (BridgeBio Pharma), which is currently under development for children with achondroplasia, according to a press release from ...